Asia Pacific Finance Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Finance Daily.

Press releases published on May 1, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
XMax Announces AI Model Agreement, Marking Major Milestone for its AI Business
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Spyre Therapeutics Announces Grants of Inducement Awards
Mountain Crest Acquisition 6 Corp. Announces Closing of $60 Million Initial Public Offering
XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q26
Ready Capital Corporation Announces First Quarter 2026 Results and Webcast Call
Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call
Farmer Brothers Stockholders Vote to Approve Proposed Acquisition by Royal Cup
Rongcheng Group Limited Announces Entering into an Agreement and Plan of Merger with GalaxyEdge Acquisition Corporation
Taitron Announces Quarterly Cash Dividend
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Heidmar Announces Filing of Its 2025 Annual Report on Form 20-F
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Share this page:

Sign up for:

Asia Pacific Finance Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.